Avichai Shimoni

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 10

Top Topics

Acute Lymphoblastic Leukemia

Stem Cell Transplantation

Prognostic Factors

Top Venues

American journal of hematology

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Ana Alarcon Tomas, Joshua Alexander Fein, Shalev Fried, Jessica R Flynn, Sean M Devlin, Warren B Fingrut, Theodora Anagnostou, Anna Alperovich, Nishi Shah, Ellen Fraint, Richard J Lin, Michael Scordo, Connie Lee Batlevi, Michal J Besser, Parastoo Bahrami Dahi, Ivetta Danylesko, Sergio A Giralt, Brandon S Imber, Elad Jacoby, Meirav Kedmi, Arnon Nagler, Maria Lia Palomba, Mikhail Roshal, Gilles A Salles, Craig Sauter, Noga Shem-Tov, Avichai Shimoni, Joachim Yahalom, Ronit Yerushalmi, Gunjan L Shah, Abraham Avigdor, Miguel-Ángel Perales, Roni Shouval
Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma. Leukemia (2022)
Maria H Gilleece, Avichai Shimoni, Myriam Labopin, Stephen Robinson, Dietrich Beelen, Gerard Socié, Ali Unal, Arnold Ganser, Antonin Vitek, Henrik Sengeloev, Ibrahim Yakoub Agha, Eleni Tholouli, Emmanuelle Polge, Florent Malard, Arnon Nagler
Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT. Blood cancer journal 11 (5) (2021)
Avichai Shimoni, Marie Robin, Simona Iacobelli, Dietrich Beelen, Ghulam J Mufti, Fabio Ciceri, Wolfgang Bethge, Liisa Volin, Didier Blaise, Arnold Ganser, Thomas Luft, Patrice Chevallier, Rainer Schwerdtfeger, Linda Koster, Theo de Witte, Nicolaus M Kröger, Arnon Nagler, Ibrahim Yakoub-Agha
Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT. British journal of haematology 195 (3) (2021)
Noga Shem-Tov, Ronit Yerushalmi, Ivetta Danylesko, Vladislav Litachevsky, Itzchak Levy, Liraz Olmer, Yaniv Lusitg, Abraham Avigdor, Arnon Nagler, Avichai Shimoni, Galia Rahav
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in haematopoietic stem cell transplantation recipients. British journal of haematology (2021)
Aleksandra Holowiecka, Sebastian Giebel, Myriam Labopin, Tomasz Czerw, Depei Wu, Liisa Volin, Gerard Socié, Ibrahim Yakoub Agha, Johan Maertens, Jan J Cornelissen, Arnaud Pigneux, Avichai Shimoni, Rainer Schwerdtfeger, Hélène Labussière-Wallet, Nigel Russell, Anton Schattenberg, Patrice Chevallier, Vladimir Koza, Caterina Ilari, Christoph Schmid, Zinaida Peric, Mohamad Mohty, Arnon Nagler
Allogeneic hematopoietic stem cell transplantation for adult patients with t(4;11)(q21;q23) KMT2A/AFF1 B-cell precursor acute lymphoblastic leukemia in first complete remission: impact of pretransplant measurable residual disease (MRD) status. An analysis from the Acute Leukemia Working Party of the EBMT. Leukemia 35 (8) (2021)
Olga Ostrovsky, Polina Baryakh, Yan Morgulis, Margarita Mayorov, Nira Bloom, Katia Beider, Avichai Shimoni, Israel Vlodavsky, Arnon Nagler
The HPSE Gene Insulator-A Novel Regulatory Element That Affects Heparanase Expression, Stem Cell Mobilization, and the Risk of Acute Graft versus Host Disease. Cells 10 (10) (2021)
Gautam Borthakur, Yishai Ofran, Martin S Tallman, James M Foran, Geoffrey L Uy, John F DiPersio, Margaret M Showel, Avichai Shimoni, Arnon Nagler, Jacob M Rowe, Jessica K Altman, Michal Abraham, Amnon Peled, Stephen Shaw, Osnat Bohana-Kashtan, Ella Sorani, Yaron Pereg, Adam Foley-Comer, Galia Oberkovitz, Tzipi M Lustig, Irit Glicko-Kabir, Arnon Aharon, Abi Vainstein-Haras, Shaul E Kadosh, Emil Samara, Ahmed N Al-Rawi, Naveen Pemmaraju, Carlos Bueso-Ramos, Jorge E Cortes, Michael Andreeff
BL-8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open-label safety and efficacy phase 2a study. Cancer 127 (8) (2020)
Avichai Shimoni, Noga Shem-Tov, Ronit Yerushalmi, Ivetta Danylesko, Arnon Nagler
Carfilzomib combined with cyclosporine and methotrexate for the prevention of graft-versus-host disease after allogeneic stem-cell transplantation from unrelated donors. Bone marrow transplantation 56 (2) (2020)
Ronit Yerushalmi, Noga Shem-Tov, Ivetta Danylesko, Roni Shouval, Arnon Nagler, Avichai Shimoni
The combination of cyclosporine and mycophenolate mofetil is less effective than cyclosporine and methotrexate in the prevention of acute graft-versus host disease after stem-cell transplantation from unrelated donors. American journal of hematology 92 (3) (2017)
Avichai Shimoni, Luca Vago, Massimo Bernardi, Ronit Yerushalmi, Jacopo Peccatori, Raffaella Greco, Noga Shem-Tov, Alessandro Lo Russo, Ivetta Danylesko, Arie Apel, Chiara Bonini, Maria Teresa Lupo Stanghellini, Arnon Nagler, Fabio Ciceri
Missing HLA C group 1 ligand in patients with AML and MDS is associated with reduced risk of relapse and better survival after allogeneic stem cell transplantation with fludarabine and treosulfan reduced toxicity conditioning. American journal of hematology 92 (10) (2017)